Silexion Therapeutics Corp. (SLXN)
0.3606
-0.03
(-8.50%)
USD |
NASDAQ |
Aug 24, 16:00
0.3602
0.00 (0.00%)
After-Hours: 20:00
Silexion Therapeutics Max Drawdown (5Y) : 99.99% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 99.99% |
| June 30, 2026 | 99.98% |
| May 31, 2026 | 99.98% |
| April 30, 2026 | 99.96% |
| March 31, 2026 | 99.93% |
| February 28, 2026 | 99.91% |
| January 31, 2026 | 99.90% |
| December 31, 2025 | 99.90% |
| November 30, 2025 | 99.87% |
| October 31, 2025 | 99.80% |
| September 30, 2025 | 99.80% |
| August 31, 2025 | 99.59% |
| July 31, 2025 | 99.48% |
| June 30, 2025 | 99.48% |
| May 31, 2025 | 99.48% |
| April 30, 2025 | 99.48% |
| March 31, 2025 | 99.48% |
| February 28, 2025 | 99.48% |
| January 31, 2025 | 99.48% |
| December 31, 2024 | 98.27% |
| November 30, 2024 | 98.27% |
| October 31, 2024 | 97.68% |
| September 30, 2024 | 95.73% |
| August 31, 2024 | 88.54% |
| July 31, 2024 | 7.29% |
| Date | Value |
|---|---|
| June 30, 2024 | 6.23% |
| May 31, 2024 | 6.23% |
| April 30, 2024 | 6.23% |
| March 31, 2024 | 6.23% |
| February 29, 2024 | 6.23% |
| January 31, 2024 | 6.23% |
| December 31, 2023 | 6.23% |
| November 30, 2023 | 6.23% |
| October 31, 2023 | 6.23% |
| September 30, 2023 | 6.23% |
| August 31, 2023 | 6.23% |
| July 31, 2023 | 5.60% |
| June 30, 2023 | 5.60% |
| May 31, 2023 | 5.60% |
| April 30, 2023 | 5.60% |
| March 31, 2023 | 5.60% |
| February 28, 2023 | 5.60% |
| January 31, 2023 | 5.60% |
| December 31, 2022 | 5.60% |
| November 30, 2022 | 5.60% |
| October 31, 2022 | 5.60% |
| September 30, 2022 | 5.60% |
| August 31, 2022 | 5.60% |
| July 31, 2022 | 5.60% |
| June 30, 2022 | 5.60% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| BioLineRx Ltd. | 98.88% |
| XTL Biopharmaceuticals Ltd. | 90.10% |
| Kamada Ltd. | 67.69% |
| Can-Fite BioPharma Ltd. | 99.43% |
| Galmed Pharmaceuticals Ltd. | 99.94% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -84.34 |
| Beta (5Y) | -0.2508 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 75.20% |
| Historical Sharpe Ratio (5Y) | -1.152 |
| Historical Sortino (5Y) | -1.058 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 52.06% |